Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
CinCor Pharma, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/28/2023 |
4
| 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Unknown transaction of 3,953,990 shares
@ $0
Unknown transaction of 487,333 shares
@ $0
Unknown transaction of 496,323 shares
@ $0 |
|
| 02/27/2023 |
4
| HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Sold 6,000 shares
@ $14.32, valued at
$85.9k
Unknown transaction of 9,803 shares
@ $0
Disposed/sold 19,608 shares
@ $0
Unknown transaction of 6,073,949 shares
@ $0 |
|
| 02/27/2023 |
4
| Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Sold 6 shares
@ $15.21, valued at
$91.3
Unknown transaction of 2,494 shares
@ $0
Disposed/sold 40,000 shares
@ $0
Unknown transaction of 100 shares
@ $0
Disposed/sold 30,178 options to buy
@ $0.92, valued at
$27.8k
Disposed/sold 145,296 options to buy
@ $5.82, valued at
$845.6k
Disposed/sold 120,380 options to buy
@ $7.62, valued at
$917.3k
|
|
| 02/24/2023 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 29,411 options to buy
@ $13.6, valued at
$400k
Disposed/sold 1,038 options to buy
@ $19.55, valued at
$20.3k
Disposed/sold 881 options to buy
@ $20.2, valued at
$17.8k
Disposed/sold 524 options to buy
@ $33.49, valued at
$17.5k
Disposed/sold 1,499 options to buy
@ $11.78, valued at
$17.7k
|
|
| 02/24/2023 |
4
| Ignelzi Troy A. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 36,324 options to buy
@ $5.82, valued at
$211.4k
Disposed/sold 58,823 options to buy
@ $13.6, valued at
$800k
|
|
| 02/24/2023 |
4
| Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 202,437 shares
@ $0
Disposed/sold 77,615 options to buy
@ $30.07, valued at
$2.3M
|
|
| 02/24/2023 |
4
| Lee June (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 47,954 options to buy
@ $16, valued at
$767.3k
|
|
| 02/24/2023 |
4
| Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Unknown transaction of 140,149 shares
@ $0
Disposed/sold 15,000 shares
@ $0
Unknown transaction of 1,500 shares
@ $0
Disposed/sold 110,136 options to buy
@ $2.55, valued at
$280.8k
Disposed/sold 13,236 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| THERO JOHN F (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Disposed/sold 36,324 options to buy
@ $5.82, valued at
$211.4k
Disposed/sold 58,823 options to buy
@ $13.6, valued at
$800k
|
|
| 02/24/2023 |
4
| de Garidel Marc (CEO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Unknown transaction of 12,500 shares
@ $0
Disposed/sold 200,000 shares
@ $0
Disposed/sold 726,483 options to buy
@ $5.82, valued at
$4.2M
Disposed/sold 601,901 options to buy
@ $7.62, valued at
$4.6M
|
|
| 01/30/2023 |
4
| de Garidel Marc (CEO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 200,000 shares
@ $0 |
|
| 01/30/2023 |
4
| Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 01/30/2023 |
4
| Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 177,000 shares
@ $0 |
|
| 01/30/2023 |
4
| Freeman Mason (Chief Medical Officer) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 01/19/2023 |
4
| Pearce Catherine (COO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Paid exercise price by delivering 3,997 shares
@ $28.75, valued at
$114.9k
Exercised 13,235 restricted stock units
@ $0 |
|
| 01/10/2023 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 1,499 options to buy
@ $11.78, valued at
$17.7k
|
|
| 11/08/2022 |
4
| Kalb Michael Wayne (EVP & CFO) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 25,437 shares
@ $0
Granted 77,615 options to buy
@ $30.07, valued at
$2.3M
|
|
| 11/08/2022 |
3
| Kalb Michael Wayne (EVP & CFO) has filed a Form 3 on CinCor Pharma, Inc. |
| 10/12/2022 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 524 options to buy
@ $33.49, valued at
$17.5k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2022 |
4
| HEALY JAMES (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Exercised 29,411 options to buy
@ $13.6, valued at
$400k
|
|
| 07/20/2022 |
4
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 881 options to buy
@ $20.2, valued at
$17.8k
|
|
| 07/20/2022 |
4/A
| Allison David D. (Director) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Granted 1,038 options to buy
@ $19.55, valued at
$20.3k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| GENERAL ATLANTIC GENPAR (BERMUDA), L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 2,426,470 shares
@ $0
Bought 1,700,000 shares
@ $16, valued at
$27.2M
Converted 8,250,000 preferred shares
@ $0 |
|
| 01/13/2022 |
4
| GENERAL ATLANTIC, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 2,426,470 shares
@ $0
Bought 1,700,000 shares
@ $16, valued at
$27.2M
Converted 8,250,000 preferred shares
@ $0 |
|
| 01/13/2022 |
4
| 5AM Partners VI, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 3,683,823 shares
@ $0
Converted 183,823 shares
@ $0
Bought 157,500 shares
@ $16, valued at
$2.5M
Bought 312,500 shares
@ $16, valued at
$5M
Converted 9,999,999 preferred shares
@ $0
Converted 2,525,000 preferred shares
@ $0
Converted 625,000 preferred shares
@ $0 |
|
| 01/13/2022 |
4
| CinRx Pharma, LLC (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 1,222,530 shares
@ $0
Converted 2,142,856 preferred shares
@ $0
Converted 2,013,749 preferred shares
@ $0 |
|
| 01/13/2022 |
4
| Sofinnova Venture Partners X, L.P. (10% Owner) has filed a Form 4 on CinCor Pharma, Inc.|
Txns:
| Converted 5,248,949 shares
@ $0
Bought 325,000 shares
@ $16, valued at
$5.2M
Converted 13,571,428 preferred shares
@ $0
Converted 4,275,000 preferred shares
@ $0 |
|
|
|
|